MENURogel Cancer Center earns re-accreditation from Commission on Cancer
Media contact: Nicole Fawcett, 734-764-2220 | Patients may contact Cancer AnswerLine 800-865-1125
The University of Michigan Rogel Cancer Center has been re-accredited by the Commission on Cancer, a quality program of the American College of Surgeons.
To earn voluntary CoC accreditation, a cancer program must meet 34 CoC quality care standards, be evaluated every three years through a survey process, and maintain levels of excellence in the delivery of comprehensive patient-centered care.
The Rogel Cancer Center was first accredited by CoC in 1932, making it one of the first cancer programs to receive accreditation.
CoC-accredited cancer centers must show they take a multidisciplinary approach to treating cancer as a complex group of diseases that requires consultation among surgeons, medical and radiation oncologists, diagnostic radiologists, pathologists and other cancer specialists. This multidisciplinary partnership, a hallmark of Rogel’s approach to treating cancer, results in improved patient care.
“Rogel’s participation with the Commission on Cancer illustrates our longstanding commitment to excellence in cancer care. Our CoC accreditation helps ensure we maintain our high standard of patient care,” said Christina Angeles, M.D., assistant professor of surgery, who spearheads the CoC efforts at Rogel.
“Patients want to have confidence in their cancer provider. Our CoC designation gives patients assurance that the Rogel Cancer Center is among the nation’s best.”
Like all CoC-accredited facilities, the Rogel Cancer Center maintains a cancer registry and contributes data to the National Cancer Data Base, a joint program of the CoC and American Cancer Society. This nationwide oncology outcomes database is the largest clinical disease registry in the world. Data on all types of cancer are tracked and analyzed through the NCDB and used to explore trends in cancer care. CoC-accredited cancer centers, in turn, have access to information derived from this type of data analysis, which is used to create national, regional, and state benchmark reports. These reports help CoC facilities with their quality improvement efforts.
“Participating in the National Cancer Database allows our researchers to tap into a rich resource to understand trends and issues in cancer care and help create solutions,” said Tasha Hughes, M.D., M.P.H., assistant professor of surgery and Rogel’s liaison to the CoC program.
Established in 1922 by the American College of Surgeons, the CoC is a consortium of professional organizations dedicated to improving patient outcomes and quality of life for cancer patients through standard-setting, prevention, research, education, and the monitoring of comprehensive, quality care. Its membership includes Fellows of the American College of Surgeons. For more information, visit: www.facs.org/cancer
The University of Michigan Rogel Cancer Center is committed to improving the health and well-being of people who have – or are at risk of getting – cancer. As a National Cancer Institute-designated comprehensive cancer center, our more than 500 members work to prevent cancer, improve outcomes for those diagnosed, and improve quality of life for cancer patients and survivors. Among 24 areas of specialty, our multidisciplinary cancer clinics offer one-stop access to teams of specialists who develop personalized treatment plans for each patient. Learn more at rogelcancercenter.org or call the Cancer AnswerLine at 800-865-1125.